Literature DB >> 2160271

[3H]phenamil binding protein of the renal epithelium Na+ channel. Purification, affinity labeling, and functional reconstitution.

P Barbry1, O Chassande, R Marsault, M Lazdunski, C Frelin.   

Abstract

This paper describes a large-scale purification procedure of the amiloride binding component of the epithelium Na+ channel. [3H]Phenamil was used as a labeled ligand to follow the purification. The first two steps are identical with those previously described [Barbry, P., Chassande, O., Vigne, P., Frelin, C., Ellory, C., Cragoe, E. J., Jr., & Lazdunski, M. (1987) Proc. Natl. Acad. Sci. U.S.A. 84, 4836-4840]. A third step was a hydroxyapatite column. The purified material consisted of a homodimer of two 88-kDa proteins that migrated anomalously in SDS-PAGE to give an apparent Mr of 105,000. Deglycosylation by treatment with neuraminidase and endoglycosidase F or with neuraminidase and glycopeptidase F indicated that less than 5% of the mass of the native receptor was carbohydrate. Sedimentation analysis of the purified Na+ channel in H2O and D2O sucrose gradients and gel filtration experiments led to an estimated molecular weight of the [3H]phenamil receptor protein-detergent-phospholipid complex of 288,000 and of the native [3H]phenamil receptor protein of 158,000. [3H]Br-benzamil is another labeled derivative of amiloride that recognized binding sites that had the same pharmacological properties as [3H]phenamil binding sites and that copurified with them. Upon irradiation of kidney membranes, [3H]Br-benzamil incorporated specifically into a 185-kDa polypeptide chain under nonreducing electrophoretic conditions and a 105-kDa protein under reducing conditions. The same labeling pattern was observed at the different steps of the purification. Reconstitution of the purified phenamil receptor into large unilamellar vesicles was carried out. A low but significant phenamil- and amiloride-sensitive electrogenic Na+ transport was observed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2160271     DOI: 10.1021/bi00456a028

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers.

Authors:  Joseph E Ippolito; Jian Xu; Sanjay Jain; Krista Moulder; Steven Mennerick; Jan R Crowley; R Reid Townsend; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-05       Impact factor: 11.205

2.  Localization of the gene for amiloride binding protein on chromosome 7 and RFLP analysis in cystic fibrosis families.

Authors:  P Barbry; B Simon-Bouy; M G Mattéi; E Le Guern; B Jaume-Roig; O Chassande; A Ullrich; M Lazdunski
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

Review 3.  Structure and function of amiloride-sensitive Na+ channels.

Authors:  D J Benos; M S Awayda; I I Ismailov; J P Johnson
Journal:  J Membr Biol       Date:  1995-01       Impact factor: 1.843

4.  Human kidney amiloride-binding protein: cDNA structure and functional expression.

Authors:  P Barbry; M Champe; O Chassande; S Munemitsu; G Champigny; E Lingueglia; P Maes; C Frelin; A Tartar; A Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

5.  Amiloride-blockable Ca2+-activated Na+-permeant channels in the fetal distal lung epithelium.

Authors:  Y Marunaka
Journal:  Pflugers Arch       Date:  1996-03       Impact factor: 3.657

6.  Primary structure of an apical protein from Xenopus laevis that participates in amiloride-sensitive sodium channel activity.

Authors:  O Staub; F Verrey; T R Kleyman; D J Benos; B C Rossier; J P Kraehenbuhl
Journal:  J Cell Biol       Date:  1992-12       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.